Versant Vantage II, L.P. - Insider Trading & Ownership

Entity
Company
Location
One Sansome Street, Suite 1650, San Francisco, CA
Summary
The estimated value of insider holdings of Versant Vantage II, L.P. is at least $10.1M dollars as of May 3, 2022. Versant Vantage II, L.P. is the 10%+ Owner of Tempest Therapeutics, Inc. and owns shares of Tempest Therapeutics, Inc. (TPST) stock worth about $10.1M.
All Insider Reports
All Insider Reports

Ownership of Versant Vantage II, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TPST Tempest Therapeutics, Inc. 10%+ Owner $10.1M Apr 29, 2022

There are no insider transactions reported by Versant Vantage II, L.P.